Metastatic castration-sensitive prostate cancer
Clinical trials for Metastatic castration-sensitive prostate cancer explained in plain language.
Never miss a new study
Get alerted when new Metastatic castration-sensitive prostate cancer trials appear
Sign up with your email to follow new studies for Metastatic castration-sensitive prostate cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Smart scans may slash radiation doses for metastatic prostate cancer
Disease control Not yet recruitingThis early-phase trial explores whether PSMA PET scans can help doctors adjust radiation therapy for men with prostate cancer that has spread to 4 to 20 spots in the body. Participants receive standard hormone therapy plus a special PET scan, then targeted radiation to all visibl…
Matched conditions: METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER
Early phase 1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a new drug combo slow advanced prostate cancer?
Disease control Not yet recruitingThis trial is investigating whether an experimental drug called XNW5004, when combined with standard anti-tumor therapies, can help control advanced prostate cancer. The study involves men with prostate cancer that has spread. Researchers are looking at how safe the combination i…
Matched conditions: METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER
Phase 2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New hope for aggressive prostate cancer: carboplatin combo tested in phase 3 trial
Disease control Not yet recruitingThis phase 3 trial tests whether adding carboplatin to standard therapy can delay cancer growth in men with aggressive prostate cancer that has spread and has either a BRCA gene mutation or neuroendocrine features. About 330 participants will receive either standard care alone or…
Matched conditions: METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER
Phase 3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC